Several mechanisms have been reported for Ag-negative relapses, including pre-existing Ag-negative tumor cells, gene mutations or alternative splicing, alterations that affect the maturation of target Ag expression, epitope masking, and lineage switch [11, 12]. Here, RENBP is linked to neoplasm.